NARA Discovery
Article Details
← Back to Search Results
Journal Article

Antinociceptive properties of new coumarin derivatives bearing substituted 3,4-dihydro-2H-benzothiazines

Masoumeh Alipour; Mehdi Khoobi; Saeed Emami; Saeed Fallah-Benakohal; Seyedeh Farnaz Ghasemi-Niri; Mohammad Abdollahi; Alireza Foroumadi; Abbas Shafiee
DARU Journal of Pharmaceutical Sciences · Vol. 22, Issue 1 · 2014

Abstract

Background Coumarins are an important class of widely distributed heterocyclic natural products exhibiting a broad pharmacological profile. In this work, a new series of coumarins bearing substituted 3,4-dihydro-2 H -benzothiazines were described as potential analgesic agents. The clinical use of NSAIDs as traditional analgesics is associated with side effects such as gastrointestinal lesions and nephrotoxicity. Therefore, the discovery of new safer drugs represents a challenging goal for such a research area. Results The target compounds 3-(3-methyl-3,4-dihydro-2 H -benzo[ b ][1,4]thiazin-3-yl)-2 H -chromen-2-ones 2a-u were synthesized and characterized by spectral data. The antinociceptive properties of target compounds were determined by formalin-induced test and acetic acid-induced writhing test in mice. Among the tested compounds, compound 2u bearing 2-(4-(methylsulfonyl)benzoyl)- moiety on benzothiazine ring and 4-(methylsulfonyl)phenacyloxy- group on the 7 position of coumarin nucleus showed better profile of antinocecieption in both models. It was more effective than mefenamic acid during the late phase of formalin-induced test as well as in the acetic acid-induced writhing test. Conclusion Considering the significant antinoceciptive action of phenacyloxycoumarin derivatives, compound 2u prototype might be further used as model to obtain new more potent analgesic drugs.

Bibliographic Information

JournalDARU Journal of Pharmaceutical Sciences
PublisherSpringer
Publication Date2014-12-01
Publication Year2014
Volume22
Issue1
Document TypeJournal Article
eISSN2008-2231
DOI10.1186/2008-2231-22-9

Access Information

NARA Access Coverage2012-01-01~Current
Journal Homepagehttps://www.springer.com/journal/40199
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.